At Improvita, we uncover critical user insights to support the design, development, and validation of medical devices, combination drug devices, and AI enhanced software as a medical device (SaMD). Key services include: Human Factors Validation & Formative Research Usability Testing for Devices, Diagnostics, and Digital Tools Patient-Centered Design for SaMD and Combination Products FDA & Notified Body-Compliant HF Studies Behavioral Science Applied to MedTech UX UX Research for Risk-Based Design Decisions HCP and Patient Engagement in Product Design Ethnographic and Contextual Inquiry in Healthcare Settings Conducting comprehensive Human Factors/Usability and User Experience studies early and throughout the development process can provide essential data necessary for FDA regulatory approval upon the first submission. The goal of the Improvita team is to optimize the user experience; let's make it easy for the user to use your product easy to use safely and efficaciously!
Looking for a particular Improvita employee's phone or email?
The Improvita annual revenue was $12.8 million in 2026.
Vita Uriyanova is the Owner of Improvita.
1 people are employed at Improvita.
Improvita is based in Madison, WI.
The NAICS codes for Improvita are [32, 32541, 54, 541, 3254, 325].
The SIC codes for Improvita are [87, 873, 2833, 283, 28].